KBC Group NV - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
KBC Group NV ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$890.0%1,2290.0%0.00%
Q2 2023$89
-1.1%
1,2290.0%0.00%
Q1 2023$90
-26.8%
1,229
-14.1%
0.00%
-100.0%
Q4 2022$123
-99.9%
1,4310.0%0.00%0.0%
Q3 2022$123,000
-3.9%
1,4310.0%0.00%0.0%
Q2 2022$128,000
-96.0%
1,431
-75.3%
0.00%0.0%
Q4 2020$3,166,000
+473.6%
5,7880.0%0.00%
-50.0%
Q3 2020$552,000
+72.5%
5,788
+101.8%
0.00%
+100.0%
Q2 2020$320,000
-79.8%
2,868
-86.8%
0.00%
-92.3%
Q1 2020$1,584,000
-62.2%
21,784
-45.8%
0.01%
-50.0%
Q4 2019$4,190,000
+84.5%
40,180
+91.8%
0.03%
-38.1%
Q4 2015$2,271,000
+13.7%
20,950
-10.2%
0.04%
+5.0%
Q3 2015$1,997,000
+1286.8%
23,319
+1531.8%
0.04%
+1900.0%
Q2 2015$144,000
-40.0%
1,429
-72.1%
0.00%
-75.0%
Q3 2014$240,000
-24.8%
5,1180.0%0.01%
+100.0%
Q2 2014$319,000
+459.6%
5,118
+507.1%
0.00%
+300.0%
Q1 2014$57,000
+29.5%
8430.0%0.00%0.0%
Q4 2013$44,0008430.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders